Target intelligence / Profile preview

Physiological cell and tissue microenvironment

Molecular classification
Other
01

Overview

The physiological cell and tissue microenvironment is the local biological system surrounding a cell, consisting of the extracellular matrix (ECM), neighboring cells (such as fibroblasts and immune cells), blood vessels, and a variety of signaling molecules like cytokines and growth factors (NCI Dictionary of Cancer Terms). It plays a critical role in regulating cellular behavior, including growth, survival, and differentiation, through both biochemical and mechanical signals (Nature Reviews Molecular Cell Biology, 2014). In pathological conditions, such as cancer or fibrosis, the microenvironment undergoes significant remodeling, often creating a niche that promotes disease progression and drug resistance (PubMed, PMID: 29117544). While the microenvironment itself is not a single molecular target, many modern therapies aim to modulate its components—for example, anti-angiogenic agents like Bevacizumab target the vascular supply, while checkpoint inhibitors like Pembrolizumab target the immune milieu (Science, 2018). Understanding the interplay between cells and their surroundings is essential for developing effective treatments that can overcome the protective or stimulatory effects of a diseased microenvironment.

Other names
Cellular microenvironmentTissue microenvironmentExtracellular nicheLocal tissue milieuStroma
02

Mechanism of action

Therapeutic strategies involve the modulation of the extracellular matrix (e.g., hyaluronan degradation), inhibition of pro-angiogenic signaling (e.g., VEGF blockade), and the alteration of immune cell infiltration and activation within the tissue niche.

03

Biological functions

HomeostasisSignal transductionCell-cell communicationStructural supportNutrient exchangeCell proliferationCell differentiation
04

Disease associations

CancerInflammationFibrosisCardiovascular diseaseNeurodegenerative disease
05

Safety considerations

Systemic toxicity due to lack of specificityDisruption of normal tissue homeostasisImpaired wound healingOff-target effects on healthy stromal cellsPotential for promoting epithelial-to-mesenchymal transition (EMT)
06

Interacting drugs

Bevacizumab

5 more in the full profile.

07

Biomarkers

Hypoxia-inducible factor 1-alpha (HIF-1α)Extracellular matrix densityInterstitial fluid pressureCytokine expression profilesVascular density

Beyond the preview

Go deeper on Physiological cell and tissue microenvironment.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Physiological cell and tissue microenvironment.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call